Kherson City Clinical Hospital

Kherson 73000

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. — Completed
• A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease — Completed